1
Cary J Reich, A Edward Osawa, Helen Tran: Hemoactive compositions and methods for their manufacture and use. Baxter Healthcare Corporation, Townsend and Townsend and Crew, March 16, 2004: US06706690 (91 worldwide citation)

Dried hemoactive materials comprise both a cross-linked biologically compatible polymer and a non-cross-linked biologically compatible polymer. The cross-linked polymer is selected to form a hydrogel when exposed to blood. The non-cross-linked polymer is chosen to solubilize relatively rapidly when ...


2
Lawrence R Hogan, Herbert Mittleman, Edward G Oilschlager, Ellen Rouch, William L Rudzena: Fluid communication device. Baxter Healthcare Corporation, Paul Flattery, Kay H Pierce, Brad Price, April 25, 1989: US04823833 (83 worldwide citation)

The present invention provides a sterile, unitized, economical device furnishing a fluid path between a plurality of solutions to be compounded and a receiving container. The device includes a plurality of fluid connectors and fluid lines sealingly connected to respective pump fittings which provide ...


3
Richard Goldhaber, Daniel F Bischof: Systems and methods for removing undesired matter from blood cells. Baxter Healthcare Corporation, Paul C Flattery, Bradford R L Price, Daniel D Ryan, December 14, 1993: US05269946 (70 worldwide citation)

Systems and methods of collecting blood cells use a first container connected to at least three transfer containers. A filtration system is provided with one transfer container, which ultimately serves as the storage container for red blood cells free of white blood cells. The two other transfer con ...


4
Alexander S Borsanyi, Michael L Jones: Implantable patient-activated fluid delivery device with bolus injection port. Baxter Healthcare Corporation, Tilton Fallon Lungmus, February 6, 1990: US04898585 (62 worldwide citation)

An implantable fluid delivery device for dispensing metered amounts of liquid medication when a pump assembly within its casing is operated by finger pressure applied to a central target zone of the casing's top wall. The top wall also includes an injection site spaced from the central target zone f ...


5
Robert A Miller, Albert L Stone: Method for filling collapsible containers. Baxter Healthcare Corporation, Kay H Pierce, Paul Flattery, Bradford Price, June 20, 1989: US04840017 (34 worldwide citation)

A flexible collapsible container is filled with fluid by connecting a fluid conduit to a tubular port which communicates through one of the walls of the container to the container interior, and rupturing a sealing diaphragm that closes the bore of the tubular port. One then passes fluid through the ...


6
Alexander S Borsanyi, Russell J Redmond, Claude A Vidal, Edmund E Spaeth: Implantable patient-activated fluid delivery device. Baxter Healthcare Corporation, Tilton Fallon Lungmus, February 6, 1990: US04898584 (29 worldwide citation)

An implantable fluid delivery device for dispensing metered aliquots of liquid medication upon finger-pressure activation of the device by a patient. The device includes a soft, deformable needle-piercable casing having a fluid reservoir in which is located a relatively-rigid, apertured support plat ...


7
Ramesh Wariar, James Han, George Lamberson, Thomas P Hartranft, Thore Falkvall: Access disconnection systems and methods. Baxter International, Baxter Healthcare Corporation, Joseph P Reagen, Bell Boyd & Lloyd, April 4, 2006: US07022098 (25 worldwide citation)

Apparatuses, devices, systems and methods for detecting access disconnection are provided. The present invention includes electrical contacts in fluid and electrical communication with a fluid passing between a patient and a medical system during therapy. In this regard, the present invention can us ...


8
Robert J Przybelski: Administration of low dose hemoglobin to increase perfusion. Baxter Healthcare Corporation, McAulay Fisher Nissen Goldberg & Kiel, March 25, 1997: US05614490 (24 worldwide citation)

This invention provides a method to therapeutically increase perfusion in a mammal comprising administering stroma-free hemoglobin at a dose ranging from the least amount effective to increase perfusion, up to a dose of about 2500 mg per kilogram of body weight.


9
Alexander S Borsanyi, Russell J Redmond: Implantable patient-activated fluid delivery device and outlet valve therefor. Baxter Healthcare Corporation, Tilton Fallon Lungmus, February 6, 1990: US04898583 (17 worldwide citation)

An implantable fluid delivery device having a deformable casing containing a fluid reservoir, a compressible pump housing, and inlet and outlet valves for controlling the flow of metered amounts of fluid from the reservoir to a catheter when a target zone of the casing's top wall is depressed. The c ...


10
Sam Rose, Glenn C Buchanan: Method for making sterile connections between fluid conduit tubes. Baxter Healthcare Corporation, St Onge Steward Johnston & Reens, October 12, 1999: US05965086 (14 worldwide citation)

Sterile interconnection between disassociated segments of thermostable, compressible fluid conduit tubing is achieved by arranging within the bore of the free end of each segment a conductive hollow metal tube so as to establish a connected fluid flow path from one segment to the other, through the ...